Aptevo Therapeutics Inc. Annual Operating Income (Loss) in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aptevo Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2024.
  • Aptevo Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$6.38M, a 0.02% increase year-over-year.
  • Aptevo Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$24.6M, a 14.8% increase year-over-year.
  • Aptevo Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$24.6M, a 14.8% increase from 2023.
  • Aptevo Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$28.9M, a 0.83% decline from 2022.
  • Aptevo Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$28.6M, a 33.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$24.6M +$4.28M +14.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 -$28.9M -$237K -0.83% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 -$28.6M -$7.24M -33.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$21.4M +$6.09M +22.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$27.5M +$13.5M +32.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$41M +$10.7M +20.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$51.7M +$2.28M +4.23% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 -$53.9M +$84.8M +61.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$139M -$77.7M -127% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 -$61.1M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.